Form 4: Core Labs CAO & Treasurer Reports Stock Transactions

Core Laboratories Inc.'s CAO & Treasurer, Teo Sow Hang, reported routine acquisitions of common stock through restricted share vesting and corresponding dispositions for tax withholding.

Summary

• Teo Sow Hang, CAO & Treasurer of Core Laboratories Inc., reported transactions on August 1, 2025.
• Acquired 200 shares of common stock at $0 per share through the vesting of restricted shares.
• Disposed of 90 shares of common stock at $10.53 per share, likely for tax withholding.
• Acquired an additional 240 shares of common stock at $0 per share through the vesting of restricted shares.
• Disposed of an additional 108 shares of common stock at $10.53 per share, likely for tax withholding.
• The restricted shares vest annually over six years, contingent on continuous service.
• Following these transactions, beneficial ownership of common stock is 7,748.334 shares.
• Beneficial ownership of derivative restricted shares is 8,004.
• The transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions related to executive compensation (vesting and tax withholding), which are neutral in nature and do not indicate significant positive or negative sentiment regarding the company's performance or outlook.

Positives

• Acquisition of shares through vesting indicates continued equity alignment between management and shareholders.
• The vesting schedule over six years suggests long-term commitment from the executive.

Negatives

• Dispositions of shares occurred at $10.53 per share, which were likely for tax withholding purposes related to the vesting.

Future Outlook

NA

Industry Context

This filing is a routine insider transaction disclosure, common across all publicly traded industries, reflecting executive compensation practices rather than specific industry trends.

Comparison to Industry Standards

• These transactions are standard for executive compensation, involving the vesting of restricted stock units and subsequent sales to cover tax obligations. This practice is widely adopted across various industries and companies, including peers in the oilfield services sector, as a means to align executive incentives with long-term shareholder value. No specific comparable companies or projects are detailed in this filing.

Stakeholder Impact

• Shareholders: The transactions represent a routine part of executive compensation, aligning management's interests with long-term shareholder value through equity ownership. The dispositions are for tax purposes and not indicative of a lack of confidence.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to executive compensation, specifically the vesting of restricted shares and subsequent sales to cover tax obligations. These pre-planned transactions (under Rule 10b5-1) are neutral events and do not provide new information to warrant a change in investment recommendation. The filing does not offer insights into the company's operational performance, financial health, or strategic direction that would influence a 'buy' or 'sell' decision. Therefore, a 'hold' recommendation is appropriate as there's no new material information to alter an existing investment thesis.

Keywords

Core Laboratories Inc., CLB, SEC Form 4, Insider Trading, Stock Vesting, Restricted Shares, Executive Compensation, Teo Sow Hang, CAO, Treasurer